|
|
|
Publications
|
|
WinPOPT:
- Zamuner S, Gomeni R. Optimal Design to
Estimate the Time Varying Receptor Occupancy Relationship in a PET
Experiment. PAGE 16 (2007)
Abstr 1099 [www.page-meeting.org/?abstract=1099]
- Petrone M, Zamuner S,
Di Iorio V, Gunn R, Laruelle M, Gomeni R. Model-based
sequential human PET study design for Optimal PK/RO assessment. PAGE 16 (2007) Abstr 1183
[www.page-meeting.org/?abstract=1183]
- Mentré F, Duffull S, Gueorguieva I, Hooker
A, Leonov S, Ogungbenro K, Retout S.
Software for optimal design in population PKPD: a comparison. PAGE 16 (2007) Abstr 1179
[www.page-meeting.org/?abstract=1179]
- Green B, Kirkpatrick CM, McLeay S, Morrish
G, Lean Bodyweight as a
Descriptor for Propofol Clearance.
AAPS Meeting 2007.
- McGree JM, Duffull SB, Eccleston JA, Ward
LC. Optimal designs for studying bioimpedance Physiol Meas
2007; 28: 1465–1483
- Denman N, Mould D, Duffull S. Study Designs to Assess the Placebo
Response (PBO-R) for Hamilton
Depression (HAMD) Scores for Depression. AAPS Poster 2006.
- Mould D, Denman N, Duffull S. Using
disease progression models as a tool to detect drug effect Clin
Pharmacol Ther 2007; 82:81-86
POPT:
- McGree JM, Duffull SB, Eccleston JA, Ward LC. Optimal designs for studying
bioimpedance Physiol Meas 2007; 28: 1465–1483
- Zhou S, Pfister M, Roy A. Optimal Sampling design and trial
simulation using POPT and NONMEM.
ASCEPT Conference 2007.
- Zhou S, Pfister M, Roy A. Optimal Sampling design and trial
simulation using POPT and NONMEM.
PAGE 16 (2007) Abstr 1215 [www.page-meeting.org/?abstract=1215]
- Hennig, S., Waterhouse, T.H., Bell, S.C., France,
M., Wainwright, C.E., Miller, H., Charles, B.G. and Duffull, S.B. A D-optimal designed population
pharmacokinetic study of oral itraconazole in adult cystic fibrosis
patients. BJCP (accepted
2006)
- Duffull, S.B., Waterhouse, T.H. and Eccleston, J.A. Some
considerations on the design of population pharmacokinetic studies.J.
Pharmacokinetic Pharmacodyn. 2005; 32:441-457
- Waterhouse, T.H., Redmann, S., Duffull, S.B. and
Eccleston, J.A. Optimal design for model discrimination and
parameter estimation for itraconazole population pharmacokinetics in
cystic fibrosis patients.J. Pharmacokinetic Pharmacodyn. 2005;
32:521-545
- Green, B. and Duffull, S.B. Prospective evaluation of
a D-optimal designed population pharmacokinetic study. J.
Pharmacokinetic Pharmacodyn. 2003; 30:145-161
- Duffull, S.B., Retout, S. and Mentré, F. The use of simulated annealing for
finding optimal population designs. Comp. Methods Programs Biomed.
2002; 69:25-35.
- Duffull,
S.B., Mentré, F. and Aarons, L. Optimal design of a
population pharmacodynamic experiment for ivabradine. Pharm. Res.
2001; 18:83-89.
|
|
|
Copyright WinPOPT 2009
|
|